Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 32: 28-32, 2007. First published October 23, 2007; doi:10.1152/physiolgenomics.00165.2007
1094-8341/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
32/1/28    most recent
00165.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petersen, M. C.
Right arrow Articles by Wakatsuki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petersen, M. C.
Right arrow Articles by Wakatsuki, T.
Physiological Genomics 32:28-32 (2007)
1094-8341/07 $8.00 © 2007 American Physiological Society

Review

Tissue engineering: a new frontier in physiological genomics

Matthew C. Petersen1,2, Jozef Lazar1,3,4, Howard J. Jacob1,4,5 and Tetsuro Wakatsuki1,2

1 Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin
2 Biotechnology & Bioengineering Center, Medical College of Wisconsin, Milwaukee, Wisconsin
3 Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin
4 Human Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin
5 Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin

Considerable progress has been made in the last decade in the engineering and construction of a number of artificial tissue types. These constructs are typically viewed from the perspective of possible sources for implant and transplant materials in the clinical arena. However, incorporation of engineered tissues, often referred to as three-dimensional (3D) cell culture, also offers the possibility for significant advancements in research for physiological genomics. These 3D systems more readily mimic the in vivo setting than traditional 2D cell culture, and offer distinct advantages over the in vivo setting for some organ systems. As an example, cardiac cells in 3D culture 1) are more accessible for siRNA studies, 2) can be engineered with specific cell types, and 3) offer the potential for high-throughput screening of gene function. Here the state-of-the-art is reviewed and the applications for engineered tissue in genomics research are proposed. The ability to use engineered tissue in combination with genomics creates a bridge between traditional cellular and in vivo studies that is critical to enabling the transition of genetic information into mechanistic understanding of disease processes.

three-dimensional cell culture; engineered tissue; gene function







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.